(Q36467055)

English

Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study Group (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

based on heuristic

inferred from title

author name string

R T Chlebowski

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

R V Smalley

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

J M Weiner

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

L E Irwin

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

A A Bartolucci

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

J R Bateman

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

1 February 1989

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

59

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

227-230

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1989.46

0 references

Proceedings: Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246985

30 September 2017

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246985

30 September 2017

Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246985

30 September 2017

Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246985

30 September 2017

Factors influencing the interim interpretation of a breast cancer trial: danger of achieving the "expected" result

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246985

28 June 2018

Meta-analyses of randomized controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246985

28 June 2018

Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246985

28 June 2018

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246985

28 June 2018

The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246985

28 June 2018

Combining results of clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246985

28 June 2018

Cortisone-thyroid therapy of metastatic mammary cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246985

21 September 2018

Chemotherapy versus hormonal therapy in advanced breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2649130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2649130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized clinical trials in breast cancer: a tabular summary. Part 2: Advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2649130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CAF in metastatic breast cancer: standard therapy or another effective regimen?

1 reference

https://pubmed.ncbi.nlm.nih.gov/2649130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B

1 reference

https://pubmed.ncbi.nlm.nih.gov/2649130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2649130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course of breast cancer patients with liver metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/2649130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/2649130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of advanced breast carcinoma to the combination of the antimetabolite, Methotrexate, and the alkylating agent, thio-TEPA

1 reference

https://pubmed.ncbi.nlm.nih.gov/2649130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1989.46

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36467055&oldid=1518435856"